Eversept Partners, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001697013

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2026 · 117 positions · Total reported value $1.87B · Top-10 concentration 48.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 66.4% · 29 new · 41 cut · 27 exited

Active Share (vs S&P 500): 97.5% · vs QQQ: 99.8% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +11.9% · vs SPY -2.9% · Prev Value $1.87B — last quarter positions weighted by this quarter price moves · ranking

In its Q1 2026 13F filing, Eversept Partners, LP disclosed 117 equity positions with a combined reported value of $1.87B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 48.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were UTHR ($156.71M), QQQ ($137.77M), ABVX ($104.05M). By sector, the heaviest allocations are Health Care 76.3%, Real Estate 5.7%. Versus the prior quarter, allocation shifted toward Real Estate (+5.7pp), Other (+1.0pp) and away from Consumer Discretionary (-0.6pp), Health Care (-1.0pp).

Versus the prior quarter, Eversept Partners, LP opened 29 new positions, trimmed 41 and fully exited 27, a turnover rate of 66.4% of positions. The portfolio's overlap with the prior quarter was 52% of names.

The largest new positions opened in Q1 2026 were VRTX ($40.19M), WELL ($35.78M), DOC ($32.55M).

Of the 27 positions fully exited versus the prior quarter, the largest were DHR ($42.64M), EXAS ($24.54M), CDTX ($21.81M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • VRTX VERTEX PHARMACEUTICALS INC · $40.19M
  • WELL WELLTOWER INC REIT · $35.78M
  • DOC HEALTHPEAK PROPERTIES INC · $32.55M
  • OHI OMEGA HEALTHCARE INVS INC · $25.66M
  • QGEN QIAGEN NV · $19.07M
  • INSM INSMED INC · $15.37M
  • HYG ISHARES TR · $14.32M
  • RGEN REPLIGEN CORP · $14.23M

Fully Exited (vs previous quarter)

  • DHR DANAHER CORP DEL · prev qtr: $42.64M
  • EXAS EXACT SCIENCES CORP · prev qtr: $24.54M
  • CDTX CIDARA THERAPEUTICS INC · prev qtr: $21.81M
  • TEVA TEVA PHARMACEUTICAL INDS LTD · prev qtr: $20.60M
  • BIIB BIOGEN INC · prev qtr: $13.72M
  • SEM SELECT MED HLDGS CORP · prev qtr: $13.46M
  • CGON CG ONCOLOGY INC · prev qtr: $12.81M
  • BMY BRISTOL-MYERS SQUIBB CO · prev qtr: $12.69M

Insider Transactions (Form 4)

Latest Eversept Partners, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Eversept Partners, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 119 US equity positions with a combined value of $1.91B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-108771 (status: Approved), registered 2017-01-11
  • Regulatory AUM (Form ADV): $2.65B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 99%, registered investment companies 1%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: eversept.com

Portfolio Structure

  • 119 positions · $1.91B reported value (Q2 2026)
  • Top 10 holdings = 46.1% of reported value
  • Largest position: UTHR (UNITED THERAPEUTICS CORP DEL) at 8.2%
  • Average position size: $16.06M

Sector Tilt

  • Health Care 88.2%
  • Real Estate 5.6%
  • Industrials 1.3%
  • (classified holdings cover 96% of value)

Quarterly Activity

  • Q2 2026: 29 new, 42 added, 41 reduced, 27 exited
  • 7 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 76.3%
Financials 0.0%
Other 15.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 264.27K $156.71M 8.38%
8.38%
Add
2 238.70K $137.77M 7.37%
7.37%
Add
3 934.42K $104.05M 5.56%
5.56%
Add
4 1.79M $98.52M 5.27%
5.27%
Reduce
5 2.17M $87.43M 4.67%
4.67%
Reduce
6 384.71K $76.94M 4.11%
4.11%
Add
7 107.00K $69.59M 3.72%
3.72%
Add
8 2.89M $67.41M 3.60%
3.60%
Reduce
9 1.79M $56.72M 3.03%
3.03%
Add
10 924.19K $53.70M 2.87%
2.87%
Reduce
11 3.57M $48.82M 2.61%
2.61%
Add
12 632.10K $47.46M 2.54%
2.54%
Add
13 90.00K $40.19M 2.15%
2.15%
New
14 79.23K $37.49M 2.00%
2.00%
Reduce
15 428.80K $37.17M 1.99%
1.99%
Add
16 180.95K $35.78M 1.91%
1.91%
New
17 1.98M $32.55M 1.74%
1.74%
New
18 143.55K $30.12M 1.61%
1.61%
Add
19 3.04M $28.94M 1.55%
1.55%
Add
20 18.83M $28.06M 1.50%
1.50%
Add
21 585.68K $25.66M 1.37%
1.37%
New
22 677.39K $25.56M 1.37%
1.37%
Add
23 8.68M $25.51M 1.36%
1.36%
Add
24 2.97M $23.32M 1.25%
1.25%
Reduce
25 476.30K $19.07M 1.02%
1.02%
New
26 194.10K $18.78M 1.00%
1.00%
Add
27 19.00K $17.48M 0.93%
0.93%
Add
28 542.61K $16.12M 0.86%
0.86%
Reduce
29 94.00K $15.37M 0.82%
0.82%
New
30 3.19M $14.99M 0.80%
0.80%
Add
31 180.00K $14.32M 0.77%
0.77%
New
32 120.78K $14.23M 0.76%
0.76%
New
33 1.41M $14.18M 0.76%
0.76%
Add
34 713.27K $13.95M 0.75%
0.75%
Reduce
35 576.58K $13.58M 0.73%
0.73%
Add
36 2.23M $13.35M 0.71%
0.71%
Add
37 321.05K $11.93M 0.64%
0.64%
New
38 207.77K $11.74M 0.63%
0.63%
Add
39 31.06K $11.73M 0.63%
0.63%
New
40 406.96K $11.50M 0.61%
0.61%
Reduce
41 40.00K $10.82M 0.58%
0.58%
Reduce
42 40.00K $9.92M 0.53%
0.53%
New
43 312.18K $9.52M 0.51%
0.51%
Add
44 70.00K $9.30M 0.50%
0.50%
New
45 285.76K $9.15M 0.49%
0.49%
Reduce
46 4.99M $8.73M 0.47%
0.47%
Reduce
47 159.71K $8.11M 0.43%
0.43%
Reduce
48 239.11K $7.78M 0.42%
0.42%
New
49 68.69K $7.60M 0.41%
0.41%
Reduce
50 129.57K $7.53M 0.40%
0.40%
Reduce

FAQ

What did Eversept Partners, LP buy in 2026-Q1?

In its 2026-Q1 13F filing, Eversept Partners, LP reported 117 equity positions worth $1.87B in aggregate; its largest disclosed positions were UTHR ($156.71M), QQQ ($137.77M), ABVX ($104.05M).

How large is Eversept Partners, LP's portfolio?

Eversept Partners, LP reported $1.87B of long equity holdings across 117 positions as of 2026-Q1. Top-10 holdings account for 48.6% of reported value.

What is Eversept Partners, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/eversept-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →